Navigation Links
Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial

Provides Update to Timeline for Second Pivotal Phase 3 Trial CL-05

CHICAGO, July 02, 2007 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. , today announced the confirmation of supplemental efficacy data from Trial CL-06, the first of two pivotal Phase 3 clinical trials designed to assess the safety and effectiveness of cethromycin, a novel once-a-day antibiotic, for the treatment of community acquired pneumonia (CAP). The Company also provided an update to the projected timeline for announcement of top-line data from the second CAP study, Trial CL-05.

The Company is hosting a conference call and live webcast at 10:00 am (EDT) today, July 2, 2007 to discuss the available data from Trial CL-06. On the call will be members of the Advanced Life Sciences management team along with Donald E. Low, M.D., a recognized authority in microbiology and infectious diseases.

Statistical Considerations For Non-Inferiority

For statistical analysis pursuant to the Company's protocol and consistent with levels established in precedent FDA antibiotic drug approvals, non- inferiority at a 95% confidence interval is established when:

    -- The delta value is 10% or less on the lower bound and includes zero on

       the upper bound when the higher clinical cure rate of either

       cethromycin or Biaxin(R) is 90% or greater.

    -- The delta value is 15% or less on the lower bound and includes zero on

       the upper bound when the higher clinical cure rate of either

       cethromycin or Biaxin(R) is between 80% and 90%.

In addition, a p-value greater than 0.05 indicates that there is not a statistically significant difference between the study drug and comparator and supports non-inferiority.

The Company previously announced cethromycin's achievement of non-inferiority in the per protocol clinical cure rate compared to Biaxin(R) (clarithromycin) in CAP (cethro
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
3. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
4. Advanced Life Sciences to Host Conference Call to Discuss Data From Cethromycins First of Two Phase 3 Pneumonia Trials
5. Progenics and Wyeth Announce Positive Results from Three-Month Clinical-Extension Study of Subcutaneous Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Advanced Illness
6. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
7. Neurologix Announces Publication of Landmark Gene Therapy Study Demonstrating Safety and Statistically Significant Improvement in Patients With Advanced Parkinsons Disease
8. Advanced Viral Research Corp. Announces Positive Preliminary Findings from Ongoing Phase II Dermatological Study
9. Clinical Data Reported on Vidaza in Hematologic Malignancies and Advanced Solid Tumors
10. Updated Study Results Reinforce Survival Benefit of Taxotere (Docetaxel) for Men with Advanced, Hormone-Resistant Prostate Cancer
11. GSKS Pazopanib Shows Positive Results in Patients with Advanced Renal Cell Carcinoma, Ovarian Cancer and Soft Tissue Sarcoma
Post Your Comments:
(Date:5/6/2015)... (NYSE: CVS ) officially announced today that it will rebuild ... fire damage during protests last week.  "As we watched ... past week or so, our hearts turned from pain to the ... Larry Merlo . "Our purpose as a company is helping ... way that we can fulfill that purpose than to reopen our ...
(Date:5/6/2015)... 6, 2015 Fibich, Leebron, Copeland, Briggs & ... settlement has been reached to resolve lawsuits involving individuals ... Actos. Actos - manufactured by Takeda Pharmaceuticals - has ... cancer. Several of the firm,s attorneys were instrumental in ... Tommy Fibich - Founding Partner of Fibich, ...
(Date:5/6/2015)... Research and Markets ( http://www.researchandmarkets.com/research/jskhnb/energy_based ) has ... - Global Strategic Business Report" report to their offering. ... US, Canada , Japan ... , and Rest of World. Annual estimates and forecasts are ... historic analysis is provided for these markets. The ...
Breaking Medicine Technology:CVS Health Announces it Will Rebuild Baltimore CVS/pharmacy Locations 2Takeda Agrees to $2.4 Billion Settlement for Actos Bladder Cancer Lawsuits 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 2Energy based Ablation Devices - Global Strategic Business Report 2015: Increasing Incidence of Cancer Bodes Well For Energy Based Ablation Devices 3
... 15, 2011 Nephros, Inc. (OTC Bulletin Board: ... marketing filtration products for therapeutic applications, infection control, and ... Inc. effected a one-for-twenty reverse stock split at 5:00 ... by the Financial Industry Regulatory Authority (FINRA) that FINRA ...
... and BALTIMORE, March 15, 2011 ... innovate, implement and commercialize next generation of medical image ... leading clinicians and advanced engineering technologists. ... international communications and information technology company, and Johns Hopkins ...
Cached Medicine Technology:Nephros Announces Split Adjusted Trade Date 2Nephros Announces Split Adjusted Trade Date 3Harris Corporation and Johns Hopkins Medicine Announce Joint Venture to Develop Innovative Medical Image Management Solutions 2
(Date:5/6/2015)... Falls Church, VA (PRWEB) May 07, 2015 ... the Impact of NSF/IPEC/ANSI 363-2014, **FDAnews Webinar**, May ... EDT, http://www.fdanews.com/NewGMPStandards , Most drugs contain ... flow aids, binding agents or other purposes that ... The globalization of the pharma industry, combined with ...
(Date:5/6/2015)... With recent headlines about the kidnapping of Bossini clothing ... from Southern China, it is becoming apparent to people all ... them. This is especially true for High Net Worth Individuals ... through the property they own, the schools their children attend ... individuals, families and companies that are at higher risk than ...
(Date:5/6/2015)... Jersey (PRWEB) May 06, 2015 With ... asthma and subject to its potentially dangerous health effects, ... state-wide program – BEAM (Breathe Easier with Asthma Management) ... The program is being funded through a $500,000 foundation ... Jersey (BGCNJ), which is implementing BEAM throughout the state. ...
(Date:5/6/2015)... As the exclusive hospital of the Tampa Bay Buccaneers, Florida ... Raymond James Stadium for all the “Bucs Babies” celebrating their ... into the “Bucs Babies” program last year. , “It ... particularly those born at the Florida Hospitals here in our ... really enjoyed my time participating in the festivities, interacting with ...
(Date:5/6/2015)... Beach, VA (PRWEB) May 06, 2015 ... and services, today announced it won the Software ... CODiE Award in the "Best Postsecondary Learning Management ... in 2011 and has been finalists for this award ... and innovation that stands out in the industry. ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces — New Standards for Excipient GMPs: Analyzing the Impact of NSF/IPEC/ANSI 363-2014 Webinar, May 27, 2015 2Health News:FDAnews Announces — New Standards for Excipient GMPs: Analyzing the Impact of NSF/IPEC/ANSI 363-2014 Webinar, May 27, 2015 3Health News:Pacific Prime China Now Offering Kidnapping & Ransom Insurance 2Health News:The Horizon Foundation for New Jersey and Boys & Girls Clubs in New Jersey Join Forces to Help Children with Asthma 2Health News:The Horizon Foundation for New Jersey and Boys & Girls Clubs in New Jersey Join Forces to Help Children with Asthma 3Health News:The Horizon Foundation for New Jersey and Boys & Girls Clubs in New Jersey Join Forces to Help Children with Asthma 4Health News:Florida Hospital and the Tampa Bay Buccaneers Celebrate “Bucs Babies” Who are Turning One this Month with a Party on the Pirate Ship 2Health News:Florida Hospital and the Tampa Bay Buccaneers Celebrate “Bucs Babies” Who are Turning One this Month with a Party on the Pirate Ship 3Health News:Edvance360 Wins 2015 CODiE Award for Best LMS, Winning Twice and Maintaining Finalist Status for Seven Years Running 2Health News:Edvance360 Wins 2015 CODiE Award for Best LMS, Winning Twice and Maintaining Finalist Status for Seven Years Running 3
... Neurobiological,Technologies, Inc. ("NTI") (Nasdaq: NTII ) today ... by The NASDAQ Stock Market that it has,regained ... Previously, the NASDAQ Listing Qualifications Department had,notified NTI ... $35 million market,value of listed securities continued listing ...
... for Baby Boomers In ... Search of Better Sex, ... during the,holidays that recipients will love. But one product is, in ... ), To view the Multimedia News Release, go to: ...
... November 20 Stora Enso, a leading producer,of ... the first,intelligent pharmaceutical packaging solution to use Cypak,s ... electronic module built,around a single RFID microchip and ... sensors are printed onto the packaging,to detect when ...
... WHO Cuts Global AIDS Estimate by Six Million; AHF Questions Numbers, Seeks ... ... As the World Health,Organization (WHO) prepares to announce a dramatic decrease in ... to 33,million in a report to be released Wednesday, AIDS Healthcare Foundation,(AHF) ...
... MYL ),announced that it completed the sale of 2.14 ... per share and 53.5 million,shares of common stock at ... filed with the Securities and Exchange Commission. The,amounts sold ... underwriters, exercise of the overallotment option. The offerings ...
... Viant, Inc., a leader in,healthcare payment and cost ... as Executive Vice President of Network,Development. Mr. Vangeison ... on delivering quality and value to many of ... Vangeison will have responsibility for all network strategy,including ...
Cached Medicine News:Health News:Give the Gift of Love With Women's Intimacy Product that Increases Pleasure for Both Partners 2Health News:Give the Gift of Love With Women's Intimacy Product that Increases Pleasure for Both Partners 3Health News:Cypak Compliancy Connection Powers Stora Enso Pharma DDSi 2Health News:WHO's New Global AIDS Numbers: 'Let's Stop Guessing,' Says AHF 2Health News:Mylan Completes $2.89 Billion of Equity Financings, Including Exercise of Overallotment Option of Mandatory Convertible Preferred Stock 2Health News:Mylan Completes $2.89 Billion of Equity Financings, Including Exercise of Overallotment Option of Mandatory Convertible Preferred Stock 3Health News:Viant Appoints Keith Vangeison as Executive Vice President of Network Development 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: